Study Stopped
Coordinator departure
Impact of a Carrier (Infection, Colonization) of Highly Bacteria Resistance on the Patient's Quality of Life Hospital Environment
QALYBHRe
2 other identifiers
observational
N/A
0 countries
N/A
Brief Summary
The quality of life of carriers detected infected or colonized by emerging highly resistant bacteria (BHRe) following the implementation of specific hygiene measures during the discovery of the microorganism has been little studied. To date, there have been no studies to determine the quality of life (QoL) in France of patients with hospitalized HBHRD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2020
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2020
CompletedFirst Posted
Study publicly available on registry
January 13, 2020
CompletedStudy Start
First participant enrolled
November 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2021
CompletedNovember 17, 2020
November 1, 2020
3 months
January 9, 2020
November 16, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Impact of the implementation of Complementary Hygiene Precautions following a carrier of emerging highly resistant bacteria on the quality of life of hospitalized patients
Measurement of the decrease in utility corresponding to the deterioration of the QOL of patients since the implementation of the Additional Hygiene Precautions (PCH) following the discovery of their emerging highly resistant bacteria (BHRe).
12 months
Study Arms (1)
Patients
Patients screened for carriers infected or colonized by emerging highly resistant bacteria.
Interventions
Eligibility Criteria
Patients infected or colonized by emerging highly resistant bacteria.
You may qualify if:
- Age\> 18 years old
- Have a positive BHRe screening during the hospital stay and / or have a positive BHRe clinical sample during the hospital stay
- Conscious patients
- All types of stays in the hospital sector
- All pathologies
You may not qualify if:
- Known patients with BHRe before hospitalization
- PCH immediately upon admission (history of hospitalization abroad, patients contacted during a previous hospitalization)
- Cognitive problem
- Patients not proficient in French (requiring an interpreter)
- Patients under guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David NARBEY, MD
Hospices Civils de Lyon
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2020
First Posted
January 13, 2020
Study Start
November 16, 2020
Primary Completion
February 1, 2021
Study Completion
February 1, 2021
Last Updated
November 17, 2020
Record last verified: 2020-11